These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26910333)

  • 1. B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients.
    Jarolim P; Claggett BL; Conrad MJ; Carpenter MA; Ivanova A; Bostom AG; Kusek JW; Hunsicker LG; Jacques PF; Gravens-Mueller L; Finn P; Solomon SD; Weiner DE; Levey AS; Pfeffer MA
    Transplantation; 2017 Jan; 101(1):182-190. PubMed ID: 26910333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia.
    Puelacher C; Wagener M; Honegger U; Assadian M; Schaerli N; Mueller D; Strebel I; Twerenbold R; Boeddinghaus J; Nestelberger T; Wildi K; Sabti Z; Sazgary L; Badertscher P; du Fay de Lavallaz J; Marbot S; Kaiser C; Wild D; Zellweger MJ; Reichlin T; Mueller C
    Clin Biochem; 2018 Feb; 52():33-40. PubMed ID: 29107010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery.
    Bolliger D; Seeberger MD; Lurati Buse GA; Christen P; Rupinski B; Gürke L; Filipovic M
    Anesth Analg; 2009 Apr; 108(4):1069-75. PubMed ID: 19299763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
    Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
    J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined measurements of cardiac troponin I and brain natriuretic peptide are useful for predicting adverse outcomes in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Baba Y; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
    Circ J; 2011; 75(4):919-26. PubMed ID: 21304210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of level of B-type natriuretic peptide with outcomes in patients with infective endocarditis.
    Shiue AB; Stancoven AB; Purcell JB; Pinkston K; Wang A; Khera A; de Lemos JA; Peterson GE
    Am J Cardiol; 2010 Oct; 106(7):1011-5. PubMed ID: 20854966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.
    Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM
    Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure.
    Tsutamoto T; Kawahara C; Nishiyama K; Yamaji M; Fujii M; Yamamoto T; Horie M
    Am Heart J; 2010 Jan; 159(1):63-7. PubMed ID: 20102868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of brachial and central blood pressures on circulating levels of high-sensitivity cardiac troponin I in the general population.
    Sugiura T; Dohi Y; Takase H; Ito A; Fujii S; Ohte N
    Atherosclerosis; 2018 Feb; 269():185-191. PubMed ID: 29366992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined determination of B-type natriuretic peptide and high-sensitivity troponin I in the postmortem diagnosis of cardiac disease.
    Bañón R; Hernández-Romero D; Navarro E; Pérez-Cárceles MD; Noguera-Velasco JA; Osuna E
    Forensic Sci Med Pathol; 2019 Dec; 15(4):528-535. PubMed ID: 31471870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of high-sensitive cardiac troponin I in asymptomatic chronic hemodialysis patients.
    Maresca B; Manzione A; Moioli A; Salerno G; Cardelli P; Punzo G; Barberi S; Menè P
    J Nephrol; 2020 Feb; 33(1):129-136. PubMed ID: 31020624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Sensitivity Cardiac Troponin I for Risk Stratification in Older Adults.
    Tang O; Matsushita K; Coresh J; Hoogeveen RC; Windham BG; Ballantyne CM; Selvin E
    J Am Geriatr Soc; 2021 Apr; 69(4):986-994. PubMed ID: 33150614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure.
    Ralli S; Horwich TB; Fonarow GC
    Am Heart J; 2005 Dec; 150(6):1220-7. PubMed ID: 16338262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate elevations of high-sensitivity cardiac troponin I and B-type natriuretic peptide in chronic hemodialysis patients are associated with mortality.
    Geerse DA; van Berkel M; Vogels S; Kooman JP; Konings CJ; Scharnhorst V
    Clin Chem Lab Med; 2013 Jun; 51(6):1321-8. PubMed ID: 23241607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
    Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
    Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study (Nord-Trøndelag Health Study).
    Lyngbakken MN; Skranes JB; de Lemos JA; Nygård S; Dalen H; Hveem K; Røsjø H; Omland T
    Circulation; 2016 Dec; 134(24):1962-1972. PubMed ID: 27815376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Biomarkers in Hypertensive Patients with Medical Treatment-Results from the Randomized TEAMSTA Protect I Trial.
    Jagodzinski A; Neumann JT; Ojeda F; Sörensen NA; Wild P; Münzel T; Zeller T; Westermann D; Blankenberg S
    Clin Chem; 2017 Dec; 63(12):1877-1885. PubMed ID: 28904053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated High-Sensitivity Troponin I During Living Donor Liver Transplantation Is Associated With Postoperative Adverse Outcomes.
    Park J; Lee SH; Han S; Kim KY; Kim GE; Park M; Lee SK; Choi GS; Ahn S; Ahn HS; Kim GS
    Transplantation; 2018 May; 102(5):e236-e244. PubMed ID: 29298237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.